$3.22B
$482,000
0.0% of portfolio
25,615
Q3 2024
Added 22.17%
$934M
$864,000
0.0% of portfolio
24,214
Q3 2024
Added 11.39%
$5.38B
$1.09 Million
0.0% of portfolio
9,554
Q2 2024
Added 10.85%
$1.18B
$228,000
0.0% of portfolio
16,058
Q2 2024
Reduced 25.91%
$11.4B
$756,000
0.0% of portfolio
4,665
Q3 2024
Added 4.39%
$8.98B
$1.4 Million
0.0% of portfolio
7,225
Q3 2024
Added 15.19%
$987M
$323,000
0.0% of portfolio
10,741
Q2 2024
Added 19.13%
$1.82B
$306,000
0.0% of portfolio
13,782
Q3 2024
Added 0.46%
$1.1B
$188,000
0.0% of portfolio
9,763
Q2 2024
Added 122.7%
$2.63B
$486,000
0.0% of portfolio
6,446
Q3 2024
Added 22.11%
$2.01B
$380,000
0.0% of portfolio
28,354
Q4 2023
Reduced 24.73%
-
$0
0.0% of portfolio
-
Q2 2024
Added 17.76%
$3.67B
$762,000
0.0% of portfolio
29,083
Q2 2024
Added 3.28%
$165M
$17,000
0.0% of portfolio
3,206
Q3 2024
Reduced 26.2%
Perspective Therapeutics Inc
-
$0
0.0% of portfolio
-
Q3 2024
New
$768M
$89,000
0.0% of portfolio
26,701
Q4 2023
Added 130.38%
$908M
$188,000
0.0% of portfolio
6,141
Q1 2024
Reduced 31.57%
$92.7B
$545,000
0.0% of portfolio
37,876
Q3 2024
Reduced 2.72%
$348M
$182,000
0.0% of portfolio
10,071
Q2 2024
Added 42.17%
$490M
$92,000
0.0% of portfolio
4,107
Q2 2020
Added 45.43%
-
$0
0.0% of portfolio
-
Q2 2024
Added 32.69%
$1.47B
$223,000
0.0% of portfolio
9,042
Q1 2024
Reduced 76.51%
$988M
$319,000
0.0% of portfolio
14,015
Q3 2024
Added 9.86%
$879M
$362,000
0.0% of portfolio
50,879
Q3 2023
Added 19.26%
$12.3B
$516,000
0.0% of portfolio
11,221
Q2 2024
Added 10.11%
$9.37B
$1.6 Million
0.0% of portfolio
16,364
Q3 2024
Added 7.22%
$4.63B
$796,000
0.0% of portfolio
2,812
Q1 2024
Reduced 16.23%
$1.27B
$346,000
0.0% of portfolio
48,663
Q3 2024
Added 10.76%
$3.79B
$670,000
0.0% of portfolio
5,027
Q1 2024
Added 6.5%
$3.6B
$1.58 Million
0.0% of portfolio
85,344
Q2 2024
Added 88.55%
$8.24B
$1.25 Million
0.0% of portfolio
15,448
Q3 2024
Added 8.5%
$759M
$59,000
0.0% of portfolio
26,826
Q4 2023
Reduced 17.0%
$1.58B
$227,000
0.0% of portfolio
29,339
Q3 2024
Added 13.79%
$4.37B
$800,000
0.0% of portfolio
5,856
Q1 2024
Reduced 6.56%
$600M
$90,000
0.0% of portfolio
8,030
Q1 2024
Added 43.39%
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 27.11%
$737M
$180,000
0.0% of portfolio
7,979
Q4 2023
Reduced 24.43%
$3.82B
$1.02 Million
0.0% of portfolio
12,201
Q2 2024
Added 12.61%
$6.91B
$1.59 Million
0.0% of portfolio
15,832
Q2 2024
Added 9.36%
$482M
$117,000
0.0% of portfolio
8,736
Q4 2023
Reduced 18.06%
$4.66B
$1.09 Million
0.0% of portfolio
22,689
Q3 2024
Added 3.04%
-
$0
0.0% of portfolio
-
Q1 2024
Reduced 28.57%
$6.59B
$1.16 Million
0.0% of portfolio
10,015
Q3 2024
Reduced 5.1%
$3.38B
$921,000
0.0% of portfolio
20,458
Q3 2024
Reduced 0.29%
$3.41B
$520,000
0.0% of portfolio
2,344
Q2 2024
Added 41.97%
$3.46B
$888,000
0.0% of portfolio
13,861
Q3 2024
Added 15.11%
$3.62B
$338,000
0.0% of portfolio
14,832
Q2 2024
Added 22.82%
$885M
$211,000
0.0% of portfolio
9,447
Q3 2023
Added 40.48%
Precision Biosciences Inc
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 8.83%
$852M
$262,000
0.0% of portfolio
4,270
Q2 2024
Added 14.63%